Janusz Sauermann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Janusz Sauermann has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Jartych
Medical University of Lublin
1 shared publication - Anna Jamroz-Wiśniewska
Department of Neurology, Medical University, Lublin, Poland
1 shared publication - Emilia Kamizela
Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland
1 shared publication - Izabela Oleksak
Student Scientific Society, Chair and Department of Neurology, Medical University of Lublin, Lublin, Poland
1 shared publication Karolina Michalska
Student Scientific Society, Chair and Department of Neurology, Medical University of Lublin, Lublin, Poland
1 shared publication- Konrad Rejdak
Department of Neurology, Medical University of Lublin, Lublin, Poland
1 shared publication
Latest Publications
- Open Access
- 9 March 2026
- Published by Medical University of Lublin in Current Problems of Psychiatry
- Vol. 26, 196-208
The role of electroconvulsive therapy (ECT) in the treatment of a life-threatening condition in a patient with paranoid schizophrenia a case report in the context of limited availability of therapy in Poland
Introduction: Schizophrenia represents a leading cause of acute psychotic episodes and is frequently associated with profound social dysfunction and in severe cases, it may result in conditions posing an immediate threat to life. Management typically involves biological treatment modalities combined with psychotherapy; however, a subset of patients develops treatment resistance. Electroconvulsive therapy (ECT) remains a key intervention for overcoming pharmacoresistance, despite its limited availability in Poland. Material and method: The article present a clinical case report and a literature review based on the MEDLINE database. Results: The case study concerns a 20-year-old woman who developed a severe, prolonged psychotic state as a consequence of treatment refusal. Owing to the critical clinical condition, confirmed pharmacoresistance and progressive secondary malnutrition, ECT was initiated as a life-saving measure under the principle of medical necessity. A marked improvement in mental status was observed after the first session. Upon completion of the full ECT course, the patient was discharged home in logical contact, without psychotic symptoms, with a diagnosis of paranoid schizophrenia. Conclusions: The case supports the conclusion that ECT is an effective method for overcoming pharmacoresistance in acute psychosis and may constitute one of the most efficacious therapeutic options. In certain situations, the benefits of ECT outweigh those of pharmacotherapy alone. This case is of particular clinical relevance as it illustrates a life-saving application of ECT. The literature review further confirms the efficacy and safety of this treatment modality. Nevertheless, access to ECT in Poland remains insufficient and excessive ancillary procedural requirements reduce its cost-effectiveness, contributing to the persistence of this limitation.
- 9 March 2026
- Published by Medical University of Lublin in Current Problems of Psychiatry
- Vol. 26, 196-208
Open AccessThe role of electroconvulsive therapy (ECT) in the treatment of a life-threatening condition in a patient with paranoid schizophrenia a case report in the context of limited availability of therapy in Poland
Introduction: Schizophrenia represents a leading cause of acute psychotic episodes and is frequently associated with profound social dysfunction and in severe cases, it may result in conditions posing an immediate threat to life. Management typically involves biological treatment modalities combined with psychotherapy; however, a subset of patients develops treatment resistance. Electroconvulsive therapy (ECT) remains a key intervention for overcoming pharmacoresistance, despite its limited availability in Poland. Material and method: The article present a clinical case report and a literature review based on the MEDLINE database. Results: The case study concerns a 20-year-old woman who developed a severe, prolonged psychotic state as a consequence of treatment refusal. Owing to the critical clinical condition, confirmed pharmacoresistance and progressive secondary malnutrition, ECT was initiated as a life-saving measure under the principle of medical necessity. A marked improvement in mental status was observed after the first session. Upon completion of the full ECT course, the patient was discharged home in logical contact, without psychotic symptoms, with a diagnosis of paranoid schizophrenia. Conclusions: The case supports the conclusion that ECT is an effective method for overcoming pharmacoresistance in acute psychosis and may constitute one of the most efficacious therapeutic options. In certain situations, the benefits of ECT outweigh those of pharmacotherapy alone. This case is of particular clinical relevance as it illustrates a life-saving application of ECT. The literature review further confirms the efficacy and safety of this treatment modality. Nevertheless, access to ECT in Poland remains insufficient and excessive ancillary procedural requirements reduce its cost-effectiveness, contributing to the persistence of this limitation.
- Open Access
- 13 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 55070
Porphyria in pregnancy with exacerbation after delivery due to COVID-19
We present a case of acute intermittent porphyria (AIP) diagnosed in a pregnant woman with subsequent exacerbation after delivery due to COVID-19 infection. The patient’s symptoms manifested with acute neurovisceral attacks - abdominal pain followed by flaccid quadriparesis, sensory disturbances, hypertension and disturbance in electrolyte levels. The blood plasma test and a 24-hour urine collection revealed increased levels of urine porphobilinogen, 5-aminolevulinic acid and uroporphyrins, which led to the diagnosis of AIP. The patient received i.v. human hemin with positive outcome. After delivery she was again admitted to the hospital due to abdominal pain and trunk hyperesthesia that occurred after a mild course of COVID-19 infection. The second administration of human hemin led to the improvement of the patient's condition. The aim of this case report is to indicate that even with severe risk factors of AIP such as infection and pregnancy, proper diagnostics can increase the chance of quick recovery.
- 13 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 55070
Open AccessPorphyria in pregnancy with exacerbation after delivery due to COVID-19
We present a case of acute intermittent porphyria (AIP) diagnosed in a pregnant woman with subsequent exacerbation after delivery due to COVID-19 infection. The patient’s symptoms manifested with acute neurovisceral attacks - abdominal pain followed by flaccid quadriparesis, sensory disturbances, hypertension and disturbance in electrolyte levels. The blood plasma test and a 24-hour urine collection revealed increased levels of urine porphobilinogen, 5-aminolevulinic acid and uroporphyrins, which led to the diagnosis of AIP. The patient received i.v. human hemin with positive outcome. After delivery she was again admitted to the hospital due to abdominal pain and trunk hyperesthesia that occurred after a mild course of COVID-19 infection. The second administration of human hemin led to the improvement of the patient's condition. The aim of this case report is to indicate that even with severe risk factors of AIP such as infection and pregnancy, proper diagnostics can increase the chance of quick recovery.